2001
DOI: 10.1590/s1413-86702001000100002
|View full text |Cite
|
Sign up to set email alerts
|

Multicenter evaluation of resistance patterns of Klebsiella pneumoniae, Escherichia coli, Salmonella spp and Shigella spp isolated from clinical specimens in Brazil: RESISTNET surveillance program

Abstract: Surveillance programs are essential to detect the increase of antimicrobial resistance, and several different programs are being conducted in many countries. The RESISTNET is a surveillance program for bacterial resistance against several antimicrobial agents initiated in 1998 among Latin American countries. In Brazil, several centers were invited to join this surveillance and a total of 11 centers (6 from São Paulo and 5 from other states) participated in the study. All results were analyzed using the WHONET … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

4
17
1
6

Year Published

2002
2002
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(28 citation statements)
references
References 3 publications
4
17
1
6
Order By: Relevance
“…The data shown in this study are consistent with data 4,13,17,18 shown for other states of Brazil and other countries from Central America, North America, Africa, Middle East 19 and India as described by Drews et al, 2010 .…”
Section: Discussionsupporting
confidence: 93%
“…The data shown in this study are consistent with data 4,13,17,18 shown for other states of Brazil and other countries from Central America, North America, Africa, Middle East 19 and India as described by Drews et al, 2010 .…”
Section: Discussionsupporting
confidence: 93%
“…Oplustil et al, did not isolate any strain of Salmonella resistant to fluoroquinolones from blood samples [27]. However, Salmonella spp.…”
Section: Discussionmentioning
confidence: 99%
“…However, Salmonella spp. strains isolated from blood samples are recognized to be more susceptible than those from stools [22]. Furthermore, the flouroquinolone tested by Gales et al was gatifloxacin, a new 8-methoxifluroquinolone that is supposed to be active against most ciprofloxacin-resistant bacteria.…”
Section: Discussionmentioning
confidence: 99%